Related Experiment Video

Updated: Sep 11, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Novel molecular targets for prostate cancer therapy

J M Kamradt1, K J Pienta

  • 1Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor 41809-0946, USA.

Seminars in Oncology
|December 22, 1999
PubMed

Insights

New advanced prostate cancer treatments target cellular structures beyond DNA. Research explores novel approaches like intracellular matrix therapy, growth factors, and angiogenesis for improved patient outcomes.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Advanced prostate cancer treatment is evolving beyond traditional chemotherapy.
  • Research is identifying novel cellular targets for therapeutic intervention.
  • Intracellular matrix-targeted therapies show promise in clinical settings.

Purpose of the Study:

  • To review current laboratory and clinical advances in advanced prostate cancer treatment.
  • To explore novel therapeutic targets including cell structure, growth factors, and angiogenesis.
  • To summarize research on metastasis and cell cycle regulation in prostate cancer therapy.

Main Methods:

  • Literature review of laboratory and clinical studies.
  • Analysis of research on cellular targets beyond DNA proliferation.
  • Examination of emerging therapeutic strategies for advanced prostate cancer.

Main Results:

  • Therapies targeting the intracellular matrix have demonstrated clinical efficacy.
  • Multiple novel targets, including cell structure and angiogenesis, are under investigation.
  • Advances in understanding growth factors, differentiation, metastasis, and cell cycle impact treatment development.

Conclusions:

  • The landscape of advanced prostate cancer treatment is expanding with novel cellular targets.
  • Targeting cell structure, angiogenesis, and metastasis offers new therapeutic avenues.
  • Continued research into these areas is crucial for developing more effective prostate cancer therapies.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...